Table 1

Baseline characteristics of the study population, data are presented as mean±SD

Bevacizumab (N=154)Ranibizumab (N=163)p Value
Age (years)76.7±7.877.6±8.10.31
Sex (male/female)(56/98)(59/104)1.00
Visual acuity (letters)57.0±13.056.4±13.50.70
Foveal thickness (µm)374.6±8.4365.0±8.10.73